Financhill
Sell
17

CRI Quote, Financials, Valuation and Earnings

Last price:
$40.34
Seasonality move :
3.61%
Day range:
$40.08 - $41.53
52-week range:
$38.84 - $86.24
Dividend yield:
7.82%
P/E ratio:
7.98x
P/S ratio:
0.51x
P/B ratio:
1.73x
Volume:
1.5M
Avg. volume:
1.6M
1-year change:
-51.79%
Market cap:
$1.5B
Revenue:
$2.8B
EPS (TTM):
$5.13

Analysts' Opinion

  • Consensus Rating
    Carter's has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 4 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $45.75, Carter's has an estimated upside of 11.75% from its current price of $40.38.
  • Price Target Downside
    According to analysts, the lowest downside price target is $41.00 representing 100% downside risk from its current price of $40.38.

Fair Value

  • According to the consensus of 4 analysts, Carter's has 11.75% upside to fair value with a price target of $45.75 per share.

CRI vs. S&P 500

  • Over the past 5 trading days, Carter's has underperformed the S&P 500 by -2.67% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Carter's does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Carter's has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Carter's reported revenues of $859.7M.

Earnings Growth

  • Carter's earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Carter's reported earnings per share of $1.71.
Enterprise value:
1.6B
EV / Invested capital:
1.15x
Price / LTM sales:
0.51x
EV / EBIT:
5.95x
EV / Revenue:
0.55x
PEG ratio (5yr expected):
0.45x
EV / Free cash flow:
6.43x
Price / Operating cash flow:
5.99x
Enterprise value / EBITDA:
4.87x
Gross Profit (TTM):
$1.4B
Return On Assets:
7.84%
Net Income Margin (TTM):
6.52%
Return On Equity:
22.18%
Return On Invested Capital:
13.9%
Operating Margin:
13.17%
Trailing 12 Months Fiscal Quarters
Period Ending 2022-12-31 2023-12-31 2024-12-31 2023-12-31 2024-12-31
Income Statement
Revenue $3.2B $2.9B $2.8B $857.9M $859.7M
Gross Profit $1.5B $1.4B $1.4B $418.2M $411M
Operating Income $388.2M $323.4M $284.7M $136.1M $113.2M
EBITDA $424.8M $400.4M $320.1M $161.2M $98.2M
Diluted EPS $6.37 $6.27 $5.13 $2.90 $1.71
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Balance Sheet
Current Assets $1.9B $1.9B $1.2B $1.1B $1.1B
Total Assets $3.4B $3.2B $2.4B $2.4B $2.4B
Current Liabilities $792.5M $717.2M $528.9M $511.9M $508.8M
Total Liabilities $2.5B $2.2B $1.6B $1.5B $1.6B
Total Equity $938M $950.2M $796.4M $845.3M $854.6M
Total Debt $989.5M $991.4M $616.6M $497.4M $498.1M
Trailing 12 Months Fiscal Quarters
Period Ending 2022-12-31 2023-12-31 2024-12-31 2023-12-31 2024-12-31
Cash Flow Statement
Cash Flow Operations $88.4M $529.1M $298.8M $323.3M $287.5M
Cash From Investing -$40.4M -$59.9M -$56.2M -$17.4M -$16.5M
Cash From Financing -$819.3M -$332.6M -$174.8M -$126M -$29.7M
Free Cash Flow $48M $469.3M $242.6M $306M $270.9M
CRI
Sector
Market Cap
$1.5B
$413.9M
Price % of 52-Week High
47.47%
70.13%
Dividend Yield
7.82%
0%
Shareholder Yield
9.2%
3.83%
1-Year Price Total Return
-51.44%
-14.97%
Beta (5-Year)
1.241
0.943
Dividend yield:
7.82%
Annualized payout:
$3.20
Payout ratio:
62.63%
Growth streak:
1 years

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Technicals

8-day SMA
Sell
Level $40.83
200-day SMA
Sell
Level $58.37
Bollinger Bands (100)
Sell
Level 0 - 0
Chaikin Money Flow
Sell
Level --
20-day SMA
Sell
Level $43.43
Relative Strength Index (RSI14)
Sell
Level 33.74
ADX Line
Neutral
Level 0
Williams %R
Neutral
Level -61.326
50-day SMA
Sell
Level $49.18
MACD (12, 26)
Sell
Level -2.79
25-day Aroon Oscillator
Sell
Level -60
On Balance Volume
Neutral
Level --

Financial Scores

Buy
Altman Z-Score (Annual)
Level (3.0938)
Buy
CA Score (Annual)
Level (-0.1832)
Buy
Beneish M-Score (Annual)
Level (-2.6312)
Sell
Momentum Score
Level (3)
Sell
Ohlson Score
Level (0.4766)
Buy
Piotroski F Score (Annual)
Level (7)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (9)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Carter's Inc makes apparel for babies and children under brand names including Carter's and OshKosh B'gosh. It sells its products through a multi-channel business model, which includes retail stores, eCommerce, and wholesale sales channels, as well as retail omnichannel capabilities in the United States and Canada, which enables it to reach a broad range of consumers around the world. The company operates in three segments; U.S. Retail, U.S. Wholesale, and International. The majority of revenue is derived from U.S. Wholesale segment. The company predominantly sources products through contract manufacturers in Asia. It has multiple distribution centers in the U.S., in addition to distribution centers in Canada and Asia that serve international customers.

Stock Forecast FAQ

In the current month, CRI has received 0 Buy ratings 4 Hold ratings, and 0 Sell ratings. The CRI average analyst price target in the past 3 months is $45.75.

  • Where Will Carter's Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Carter's share price will rise to $45.75 per share over the next 12 months.

  • What Do Analysts Say About Carter's?

    Analysts are divided on their view about Carter's share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Carter's is a Sell and believe this share price will drop from its current level to $41.00.

  • What Is Carter's's Price Target?

    The price target for Carter's over the next 1-year time period is forecast to be $45.75 according to 4 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 4 analysts rate the stock a Hold.

  • Is CRI A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Carter's is a Hold. 4 of 4 analysts rate the stock a Hold at this time.

  • How Can I Buy Shares Of CRI?

    You can purchase shares of Carter's via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Carter's shares.

  • What Is The Carter's Share Price Today?

    Carter's was last trading at $40.34 per share. This represents the most recent stock quote for Carter's. Yesterday, Carter's closed at $40.38 per share.

  • How To Buy Carter's Stock Online?

    In order to purchase Carter's stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Shopify a Millionaire Maker?
Is Shopify a Millionaire Maker?

Shopify (NYSE:SHOP) is an eCommerce platform, business services provider and…

Is Alphabet Stock No Longer a Good Bet?
Is Alphabet Stock No Longer a Good Bet?

Alphabet tripled its price per share over the past 5…

Pepsi Vs Coke Stock: Which Is Best?
Pepsi Vs Coke Stock: Which Is Best?

Coca-Cola (NYSE:KO) and PepsiCo (NYSE:PEP) are two of the largest…

Stock Ideas

Buy
52
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Sell
48
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
51
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 39x

Alerts

Buy
52
RGC alert for Mar 19

Regencell Bioscience Holdings [RGC] is down 0.66% over the past day.

Sell
49
SRPT alert for Mar 19

Sarepta Therapeutics [SRPT] is up 8.72% over the past day.

Sell
48
CVNA alert for Mar 20

Carvana [CVNA] is up 5.74% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock